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Ricardo José Dunder,1 Luis Paulo Manzo,1 Marcelo Aparecido da Silva,3 Wagner Vilegas,3
Ariane Leite Rozza,4 Cláudia Helena Pellizzon,4 Lourdes Campaner dos Santos,3
and Alba Regina Monteiro Souza Brito2
1 Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (UNICAMP),
13083-970 Campinas, SP, Brazil
2 Departamento de Biologia Estrutural e Funcional, Instituto de Biologia, UNICAMP, 13083-970 Campinas, SP, Brazil
3 Departamento de Quı́mica Orgânica, Instituto de Quı́mica, UNESP, 14800-900 Araraquara, SP, Brazil
4 Departamento de Morfologia, Instituto de Biociências, UNESP, 18618-970 Botucatu, SP, Brazil
Correspondence should be addressed to Felipe Meira de Faria, defaria.felipe@gmail.com
Received 11 July 2012; Accepted 23 August 2012
Academic Editor: Vassya Bankova
Copyright © 2012 Felipe Meira de Faria et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Male Unib-WH rats were pretreated for two weeks with butanolic (BuOH) and ethyl acetate (EtOAc) fractions. Colitis was induced
by rectal administration of TNBS, the treatment continued, and animals were sacrificed on day 7 after the TNBS administration.
Phytochemical studies were performed in order to provide the characterization of the tannins present in the bark of R. mangle.
Results showed that EtOAc fraction increased the levels of IL-10 (∗∗P < 0.01) and diminished the levels of TNF-α (∗∗∗P < 0.001)
and IL-6 (∗∗P < 0.01). BuOH fraction reduced the MPO activity (∗∗P < 0.01) and levels of TBARS (∗∗∗P < 0.001); it also
increased COX-1 expression, diminished the levels of TNF-α (∗∗∗P < 0.001), and increased the levels of IL-12 (∗∗∗P < 0.001).
Besides, both treatments augmented the levels of GSH (∗P < 0.05), the activity of GSH-Px (∗∗P < 0.01 for BuOH fraction and
∗∗∗P < 0.001 for EtOAc fraction), and CAT (∗∗P < 0.01). In conclusion, both treatments ameliorated the injury induced by
TNBS through different mechanisms, probably by their chemical composition which directed its activity into an antioxidant or
anti-inflammatory response, leading to an immune modulation.
1. Introduction
Inflammatory bowel diseases (IBDs) such as ulcerative colitis
(UC) and Crohn’s disease (CD) have complex etiologies but
are simply characterized by chronic active intestinal inflam-
mation that waxes and wanes. The main features of these
diseases are a robust inflammatory response of unknown ori-
gin associated with mucosal injury and increased epithelial
permeability, invasion of commensal bacteria into the subep-
ithelial space or lamina propria, and massive recruitment of
neutrophils [1].
The UC primarily affects the mucosal lining of the
colon and rectum, whereas CD usually affects the whole
intestinal wall and potentially may extend to any part of the
gastrointestinal tract [2]. Intestinal homeostasis requires a
controlled innate immune response to the microbiota, which
is recognized by toll-like receptors (TLRs) and nucleotide-
binding oligomerization domain- (NOD-) like receptors on
the epithelial and immune cells. This recognition process
contributes to tolerance, but when the process is dysregu-
lated, inflammation ensues. In CD, abnormalities of innate
immunity are linked to variants of receptor genes, the prod-
ucts of which normally mediate microbial recognition [3].
Various proinflammatory mediators such as cyclooxy-
genases (COX-1 and COX-2), tumor necrosis factor-alpha
(TNF-α), interleukin-6 (IL-6), and interleukin-12 (IL-12),
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the presence of highly activated inflammatory cells such
as neutrophils, dendritic cells, macrophages, and excessive
production of reactive oxygen species (ROS) have been
implicated in the pathogenesis of this disease [4].
Many polyphenolic compounds have been studied for
their intestinal anti-inflammatory activity, whereas the main
effect of these compounds on inflammatory conditions is due
to the inhibition of proinflammatory markers [5, 6]. In this
context, medicinal plants which accumulate polyphenolic
compounds have an important role in the investigation of
novel therapeutics agents.
Rhizophora mangle is a mangrove plant which is a rich
source of phenolic compounds, especially condensed and
hydrolysable tannins; its bark is known as a traditional
medicine in Brazil and Caribbean countries [7]. In recent
years, various authors have described some activities such as
antioxidant [8], anti-inflammatory [9], wound healing [10]
and antiulcer [7, 11]. The present work aimed at evaluating
the effects of Rhizophora mangle extracts on the experimental
TNBS-induced colitis in rats.
2. Material and Methods
2.1. Animals. Unib-WH male rats (180–250 g) obtained
from the breeding of the Universidade Estadual de Campinas
(CEMIB/UNICAMP) were used. Animals were fed with a
certified Nuvilab CR-diet, with free access to tap water, and
were housed on a 12 h light/dark cycle at 60 ± 1% humidity
and a temperature of 21 ± 2◦C.
2.2. Plant Material and Preparation of the Extracts. The
barks of Rhizophora mangle L. were collected in “Estuário
de Santos,” Santos, SP, Brazil. Professor Msc. Paulo Salles
Penteado Sampaio authenticated the botanical identity of the
plants, and a voucher specimen (HUSC-P.S.P. Sampaio et al.,
800) was deposited to the (Herbário da Universidade Santa
Cecı́lia HUSC). The preparation of the extracts of the bark
of Rhizophora mangle as well as their phytochemical analysis
was performed according to de-Faria et al. [11].
2.3. FIA-ESI-IT-MS. The fingerprints were obtained in a
mass spectrometer LCQ Fleet (Therma Analitica), equipped
with a direct injection dispositive via continuous flow
injection analysis (FIA). ESI fingerprints in the negative ion
mode of R. mangle extract and fractions were acquired
and accumulated over 60 s and spectra were scanned in a
range between m/z 50 and 1200, and multiple fragments
(MS2, MS3) were performed in an ion-trap interface (IT).
Capillary and spray voltages were set at −4 V and −5 kV,
respectively, with a desolvation temperature of 280◦C, carrier
gas (N2) flow rate 60 (arbitrary units). Firstly, a full-scan
fingerprint was obtained, after that, MSn experiments were
made from the first scan of the preselected precursor ions
with collision energy between 25% and 30% of total energy
of the equipment.
The Xcalibur software version 1.0 (Therma Scientific)
was used during the acquisition and spectrometric data
processing.
2.4. Experimental Colitis. Male Unib-WH rats were ran-
domly assigned to four groups (n = 8); two of them
(noncolitic and control groups) received no treatment, and
the others received, orally, daily for 3 weeks, 0.5 mg/Kg of
BuOH fraction, 1.5 mg/Kg of EtOAc fraction (suspended in
saline 10 mL/kg). Both noncolitic and control groups (colitic
nontreated) were given daily 10 mL/kg of saline. Two weeks
after the treatment started, the rats were fasted overnight and
those from the control and treated groups were rendered
colitis by the method originally described by Morris et al.
[12]. Briefly, they were anaesthetized with halothane and
given 10 mg of TNBS dissolved in 0.25 mL of 50% ethanol
(v/v) through a Teflon cannula inserted 8 cm through the
anus. Rats from the noncolitic group were administered
intracolonically with 0.25 mL of phosphate-buffered saline
instead of TNBS. Behavior, body weight, and stool consis-
tency were recorded daily throughout the experiment. All
rats were killed with an overdose of halothane 1 week after
induction of colitis, and the colon was removed aseptically
and placed on an ice cold plate and longitudinally opened.
2.5. Assessment of Colonic Damage. For each animal, the dis-
tal 10 cm portion of the colon was removed, slightly cleaned
in physiological saline for faecal residues removal, and
weighed. Macroscopic inflammation scores were assigned
based on clinical features of the colon (score 0–10: 0
(no damage), 1 (focal hyperaemia), 2 (ulceration without
hyperaemia or bowel wall thickening), 3 (ulceration with
inflammation at 1 site), 4 (≥2 sites of ulceration and
inflammation), 5 (major sites of inflammation >1 cm along
the organ), 6–10 (major sites of inflammation >2 cm along
the organ)). Stool consistency (score 0-1) was evaluated
according to the criteria of Bailón et al. [13] and Vicario
et al. [14]. Pieces of inflamed colon were collected and
subsequently divided into longitudinal segments and frozen
in liquid nitrogen for further measurement of biochemical
parameters.
2.5.1. Antioxidant Assay
(1) Levels of Glutathione (GSH). GSH levels of colonic tissue
of animals were determined by Ellman’s reaction using
5′5′-dithio-bis-2-nitrobenzoic acid (DTNB) as described by
Anderson [15]. The intensity of the yellow colour was read at
412 nm.
(2) Glutathione Peroxidase Activity (GSH-Px). GSH-Px ac-
tivity was quantified by following the decrease in absorbance
at 365 nm induced by 0.25 mM H2O2 in the presence of
reduced glutathione (10 mM), NADPH, (4 mM), and 1 U
enzymatic activity of GSH-Px [16].
(3) Catalase (CAT). Catalase activity was performed accord-
ing to the method described by Aebi [17]. The samples
were homogenized (1 : 200) in phosphate buffer (50 mM, ph
7.0) and triton x-100 (9 : 1). Then, samples were centrifuged
(7000 g, 4◦C, 15 minutes); for 200 μL of the homogenate were
added 100 μL of H2O2 (30 mM). Absorbance was measured
at 240 nm for 2 minutes. The catalase activity was expressed
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as U/mg of protein, and U of enzyme activity is defined as the
amount of enzyme required to degrade 1 μmol of H2O2/s/mg
of protein.
(4) Myeloperoxidase Activity (MPO). MPO activity in the
colonic mucosa was measured by the method proposed by
Krawisz et al. [18] to evaluate neutrophil accumulation. The
tissue was minced with hexadecyltrimethylammonium bro-
mide (HTAB) buffer on ice and homogenized for three times
(3 s) on ice; the homogenizer was rinsed twice with 1 mL of
HTAB, the homogenate and washes were sonicated for 10 s,
freeze-thawed three times, then, aliquots of homogenate were
mixed with a reaction buffer of 50 mM phosphate buffer, pH
6.8, containing 0.005% H2O2 and 1.25 mg/mL o-dianisidine
dihydrochloride and then measured at 460 nm.
(5) Estimation of Lipid Peroxidation (TBARS). The homo-
genate of the colon was diluted in 0.15 M KCl (ratio 1 : 10).
Then, to 0.5 mL of this homogenate, 0.2 mL of dodecyl sul-
fate (8.1%), 1.5 mL of acetic acid (20%, adjusted with NaOH
solution to pH 3.5), 1.5 mL thiobarbituric acid (0.8% w/v),
and 0.3 mL of distilled water were added. All samples were
left in water bath set at 95◦C for 1 hour. After this period, the
samples were cooled and added to 1 mL of distilled water and
5 mL of the mixture n-butanol : pyridine (15 : 1, v/v), shaken
in vortex for 1 min and centrifuged at 1400 G for 10 minutes.
The absorbance of organic layer was determined at 532 nm.
TEPP (1,1,3,3-tetraethoxypropane) diluted in ethanol was
used as standard. The results were expressed as picomoles of
substances that react with thiobarbituric acid (TBARS) per
mg of protein (nmol TBARS/mg protein) [19].
2.5.2. Determination of the Cytokine Levels. Tissue homo-
genate was centrifuged, and the supernatant was stored at
−70◦C. Cytokine detection was performed by enzyme-linked
immunosorbent assay (ELISA) for TNF-α, IL-6 (DY 406), IL-
10 (DY 522), and IL-12 (p70) (DY 419) with the Duoset kit
(R&D Systems, Minneapolis, MN, USA).
2.5.3. Western Blotting Analysis. Frozen colon samples were
homogenized in 1 mL of cold buffer containing phos-
phate buffer-PB 0.1 M, pH 7.4, and protease inhibitor
cocktail-1% (Sigma-Aldrich P-8340). Homogenates were
centrifuged (12,000×g, 15 min, 4◦C), and the supernatants
were collected and stored at −80◦C. Protein concentration
of the homogenate was determined following Bradford’s
colorimetric method [20]. Then, samples were treated with
Laemmili buffer (PB 0.5 M, pH 6.8; glycerol, sodium dodecyl
sulfate (SDS) 10%, bromophenol 0.1%, β-mercaptoethanol)
in a 1 : 1 proportion. Equal amounts of protein from samples
(100 μg) were separated on 10% acrylamide gel by sodium
dodecyl sulfate polyacrylamide gel electrophoresis. In the
next step, proteins were electrophoretically transferred onto
a nitrocellulose membrane and incubated with specific pri-
mary antibodies: COX-1(160109, Cayman Chemical, USA)
and COX-2 (160126, Cayman Chemical, USA) at 1 : 500 dilu-
tion. Each membrane was washed three times for 10 min and
incubated with HRP-Goat Anti-Rabbit (Invitrogen 656120)
(for COX-1 and COX-2, all diluted at 1 : 5000). To prove
equal loading, the blots were analyzed with standard protein
dye ponceau [21]. Immunodetection was performed using
enhanced chemiluminescence light-detecting kit (SuperSig-
nal West Femto Chemiluminescent Substrate, Pierce, IL,
USA). Densitometric data were performed with G-BOX,
Syngene following normalization to the control (ponceau) by
GeneSys software.
3. Histology
The slides were observed after haematoxylin and eosin
(HE) staining. Histological analyses were made using a
Leica microscope associated with Leica Q-Win Software 3.1
(Leica-England), from the Image Analysis Laboratory of the
Department of Morphology, UNESP Botucatu.
4. Statistical Analysis
Results were expressed as mean ± standard error of means
(SEM). The statistical significance of each test group in
relation to the control was calculated using ANOVA followed
by Dunnet or Tukey’s t-test.
5. Results
The FIA-ESI-ITMS/MS technique with sample direct injec-
tion has been used as a quick, efficient, and sensitive tool.
It is capable of generating specific information about the
chemical composition of matrix complex, which presents
substances with a broad range of molecular weight, as well as
medium and high polarity substances, such as phenolic acids,
proanthocyanidins, catechins, and flavonoids, commonly
found in polar extracts of plants [22].
Regarding these characteristics, FIA-ESI-IT-MS/MS as-
says were made to obtain and compare the fingerprints of
the acetone : water 7 : 3 extract and active fractions, Butanolic
(BuOH fraction) and Ethyl Acetate (EtOAc fraction), in
negative mode, which allows us to establish and confirm
the similarity (or not) of the chemical composition of these
extracts and fractions.
The investigation of the full scan mass spectra reveals
the presence of various substances, which are represented
by the precursor ions of the deprotonated molecules ([M–
H]−) (Table 1) for the extract and fractions obtained from
the barks of Rhizophora mangle.
The ion at m/z 289 was assigned to the deprotonated
molecule of (epi)catechin whose fragmentation led to the
base peak at m/z 137, which represents C-ring cleavage
through a retro-Diels-Alder (RDA) mechanism [23, 24].
A minor product ion at m/z 271 was due to the loss of
water with double-bond formation (Table 1). The chirality
of the C3 on the flavan-3-ols cannot be differentiated by
mass spectrometry. Designations of the epimer configuration
are generally based on the relative abundance of the “epi”
configuration as polyphenolic components of tea infusions
and extracts [25, 26]. In our case, we designated the
compounds as [epi] catechins.
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Figure 1: Direct flow injection ESI-IT-MS fingerprint spectra in full scan, obtained in negative ion mode. (a) Normal mass scan in the range
of m/z 50–1200 of the acetone : water (7 : 3, v/v) extract, (b) normal mass scan in the range of m/z 50–1200 of the BuOH fraction, and (c)
normal mass scan in the range of m/z 50–1200 of the EtOAc fraction. For spectrometric conditions, see Section 2.
Table 1: ESI-MS and ESI-MSn product ions of proanthocyanidins
and procyanidins occurring in the bark of R. mangle.
[M–H]− Product ions
289 137 [M–152–H]−, 271 [M–18–H]−
577 289 [M–288–H]−, 137 [M–152–H]−, 271 [M–18–H]−
597 451 [M–146–H]−
1173
885 [M–288–H]−, 733 [M–288–152–H]−,
587 [M–288–152–146–H]−
In a first class of secondary metabolites, the precursor ion
of (epi)catechin formed by interflavonoidic ligation between
catechin units of m/z 577 (dimer), [M–H]−, was found in
the full scan of the extract (Figures 1(a), 1(b), and 1(c),
Table 1, Figure 2). Another catechin derivative, comprising
two hexoses, was identified on m/z 597. The spectrum MS2
provided a loss of 146 Da probably due to the loss of a
terminal rhamnose, affording the ion m/z 451 (Table 1,
Figure 2).
Fragmentation MS/MS of precursor ion of m/z 1173
(Figure 1(a)) produced base peak of m/z 885; this ion was
generated by the elimination of one unit of (epi)catechin
[M–288–H]− of the (epi)catechin unit of this trimer (Table 1,
Figure 3).
In order to verify the results described above, MS3 ex-
periments for the main observed peaks were performed.
The MS3 of ion on m/z 773 refers to a loss of a 152 Da








Epicatechin, m/z 289 = R1 = OH, R2 = H
Epicatechin dimer, m/z 577 = R1 = OH, R2 = catechin
Epicatechin diglucoside, m/z 597 = R1 O-glc-(6→1)-rham, R2 = H
Figure 2: Epicatechins identified in the barks from R. mangle by
FIA-ESI-IT-MS/MS, negative mode.
[M–288–152–H]− formed due to RDA fragmentation
(Figure 3). Another consistent proposal was used to explain
the presence of the ion on m/z 587, generated by the mech-
anism of quinone-methide (QM) fragmentation, occurring
on D-ring of the superior unit with loss of residuum 1,3,5-
trihydroxybenzene glucoside sequence for the elimination
of the resultant fragment of retro-Diels-alder (RDA) on
the C-ring of the central unit [M–288–152–H]− (Table 1,
Figure 3).
On the mechanism of fragmentation involving the QM
cleavage, the localization of diglucoside on the superior unit
of the deprotonated molecule was postulated based on a
cleavage of the interflavonoidic ligation between the C-ring
of the superior unit and the D-ring of the central unit
(Figure 3). The evidence that the glucose is in the superior
unit of the trimer is given by the ion m/z 885. This ion is the
result of an elimination of the lower unit of catechin (G-I-
rings), with consequent formation of the fragment in which
superior unit is a diglucoside catechin (A, B and C-rings) and
the lower unit containing a QM system (D-, E-, and F-rings).
Such fragment is impossible to be released if the glucose is in
the lower unit of the trimer.
Proanthocyanidins are exclusively constituted by equiva-
lent units of (epi)catechins that present one interflavonoidic
ligation, which are called procyanidins type B. Thus, the
precursor ions of m/z 577, m/z 885, and m/z 1173 are
indicatives of the procyanidins type-B [27]. However, as in
MS techniques, any differentiation was realized, as well as
any information about the position and stereochemistry of
the interflavonoidic ligation.
The oral administration of BuOH fraction and EtOAc
fraction for 21 days attenuates the macroscopic colon injury
caused by the TNBS. Both treatments were capable of
diminishing the extension of the lesions, although only
BuOH fraction provided significant changes in adhesion,
extension of lesions, and score.
BuOH fraction and EtOAc fraction maintained the levels
of GSH at physiological patterns, as well as the activity of
GSH-Px and Catalase; moreover, the GSH-Px activity was
found increased in both treatments.
Only BuOH fraction exerts effects on the MPO activity
and on lipid peroxidation in colonic tissue, reducing the
MPO activity and TBARS levels.
The treatments were capable of modulating the levels of
cytokines in inflamed colon, EtOAc fraction diminished the
levels of proinflammatory cytokines TNF-α, IL6, and IL-12,
and it also augmented IL-10 levels, an anti-inflammatory
cytokine; BuOH fraction decreased the levels of TNF-α and
IL12.
The treatments (BuOH fraction and EtOAc fraction)
were not capable of decreasing the expression of COX-2
(Figure 4). COX-1 expression was found at physiological
levels in all groups, except BuOH fraction treatment which
showed an increased expression (Figure 4).
The representative histological evaluation shows normal
colonic mucosa (Figure 5(a)) compared with colitic animals:
nontreated (Figure 5(b)), BuOH fraction (Figure 5(c)), and
EtOAc fraction (Figure 5(d)). Despite a nonquantitative
analysis, it is remarkable that BuOH fraction presents
the mucosa without marked reduction of inflammatory
infiltrate.
6. Discussion
This study focused on the beneficial effects of the BuOH
fraction and EtOAc fraction of the bark of Rhizophora mangle
in TNBS-induced chronic colitis in rats. R. mangle has been
studied in our laboratory in the recent years, and we have
demonstrated its antiulcer [11] and antioxidant [8] effects
in previous works. In the present work, we continued R.
mangle study based on its benefits to treat gastrointestinal
diseases; thus, we selected both fractions and the respective
active doses (0.5 mg/Kg—BuOH fraction and 1.5 mg/Kg—
EtOAc fraction) found in the previous studies cited.
Here, we showed the protective effects of both fractions
in an experimental model of colitis, where the treatment
with fractions of R. mangle results in the amelioration of
the colonic mucosa injury (Table 2), the improvement of
antioxidant contents (GSH) and enzymes (GSH-Px, catalase)
as well as the modulation of inflammatory markers (MPO,
TBARS, COX-1, and COX-2) and cytokines (TNF-α, IL-6,
IL-12, and IL-12).
The fingerprint of the R. mangle acetone : water (7 : 3, v/v)
extract and BuOH fraction and EtOAc fraction obtained by
FIA-ESI-ITMS/MS corroborate with the first proposal of the
presence of tannins from the polymerization of catechins.
The suggested fragmentations for ions of some identified
molecules reveal the presence of proanthocyanidin and its
possible derivatives O-glucoside. A more comprehensive
discussion for another precursor ions was recently reported
by our group [27] where the FIA-ESI-IT-MS analysis helped
to solve the chemical composition of the phytopreparation
complex. With this fingerprint of R. mangle, it is also possible
to verify the similarity between the extract and the active
fractions, probably by the presence of procyanidins.
The TNBS model of colitis induces a transmural lesion
with pathological characteristics resembling human Crohn’s

























































































































Figure 3: Main fragmentation pathways proposed of a trimer proanthocyanidin identified in the extract acetone : water (7 : 3, v/v) and BuOH
fraction and EtOAc fraction from the barks of R. mangle. The mechanisms principal: RDA (retro-Diels-alder) and QM (quinone methide).
Table 2: Effects of BuOH fraction and EtOAc fraction on parameters observed in colon of rats submitted to colitis induced by TNBS.
Group n Score Lesion (cm) Weigh/length (mg/cm) Adhesion Diarrhea
Noncolitic 6 0∗∗∗ 0∗∗∗ 91.6 ± 2.5∗∗∗ 0∗∗∗ 0∗∗∗
Colitic nontreated 10 9.2 ± 0.6 5.5 ± 0.8 225.6 ± 56.7 1.5 ± 0.5 1.0 ± 0.0
BuOH fraction 0.5 mg/Kg 10 8.1 ± 0.8∗ 4.3 ± 0.8∗ 217.8 ± 18.0 0.4 ± 0.6∗∗ 0.7 ± 0.4
EtOAc fraction 1.5 mg/Kg 9 8.3 ± 1.0 4.4 ± 1.3∗ 227.3 ± 40.2 1.0 ± 0.7 0.7 ± 0.4
Results are presented as mean ± SEM ANOVA followed by Dunnett’s t-test, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from colitic
nontreated.
disease; in this context and in order to evaluate the signif-
icance of the therapeutic use of the procyanidins from the
bark of Rhizophora mangle, the protocol of TNBS-induced
colitis in rats was used.
The production of proinflammatory cytokines, such
as interleukin-6, interleukin-12, and tumor necrosis factor
(TNF-α), is universally increased in patients with inflam-
matory bowel disease. Abnormalities of adaptive immunity
that differentiate ulcerative colitis from Crohn’s disease are
defined by mucosal CD4+ T cells, which were initially
divided in two lineages: Th1 and Th2 T cells. Crohn’s disease
is a Th1-like condition [3].
The characteristic inflammatory response begins with
an infiltration of neutrophils and macrophages, which then
release chemokines and cytokines. Neutrophil infiltration
into the inflamed mucosa is one of the most prominent
histological features observed in IBD. Activated neutrophils
produce reactive oxygen and nitrogen species within intesti-
nal mucosa inducing an oxidative stress, which plays a
significant role in the pathogenesis of IBD [28]. Regard-
ing this knowledge, our results show that treatment with
BuOH fraction, but not EtOAc fraction, decreased MPO
activity (Table 4). This could be related to the lower injury
found in this group, although this finding is linked to
the evaluation of other ROS mediators, as shown in the
following.
Inflammatory mediators, including reactive oxygen spe-
cies (ROS) and cytokines, contribute to the inflammatory
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Table 3: Effect of BuOH fraction and EtOAc fraction on colonic GSH level, GSH-Px, and catalase activities in TNBS-induced colitis in rats.






Noncolitic 8.320 ± 1.720∗∗ 11.070 ± 0.638∗ 17.510 ± 3.198∗∗
Colitic nontreated 1.028 ± 1.026 4.472 ± 0.409 1.459 ± 1.082
BuOH fraction 0.5 mg/Kg 6.548 ± 0.935∗ 11.620 ± 0.869∗∗ 15.910 ± 2.409∗∗
EtOAc fraction 1.5 mg/Kg 6.706 ± 1.969∗ 14.850 ± 1.573∗∗∗ 15.660 ± 3.380∗∗
Results are presented as mean ± SEM ANOVA followed by Dunnett’s t-test, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from colitic
nontreated.





(μmol TBARS/mg of protein)
Noncolitic 0.642 ± 0.061∗∗ 4.294 ± 0.707∗∗
Colitic nontreated 2.891 ± 0.740 5.737 ± 0.139
BuOH fraction 0.5 mg/Kg 0.896 ± 0.102∗∗ 4.171 ± 0.106∗∗∗
EtOAc fraction 1.5 mg/Kg 2.264 ± 0.429 7.218 ± 0.776














































Figure 4: Effects of oral administration during 3 weeks of BuOH
fraction and EtOAc fraction on COX-1 and COX-2 expression in
colonic tissue of rats submitted to TNBS-induced colitis. Densito-
metry was made following normalization with ponceau. Results are
presented as mean ± SEM ANOVA followed by Dunnett’s t-test,
∗P < 0.05 and ∗∗P < 0.01 significantly different from nontreated.
cascade, modulating the immune response in IBD; TNF-α
can activate oxidative stress-responsive genes which amplify
and prolong inflammation [29]. Several studies have shown
that ROS play an important role in the pathogenesis of IBD;
excessive production of ROS in mucosal cells induces an
immediate inflammatory immune response which directly
or indirectly enhances the damage to intestinal epithelial
cells, subsequently, harming the mucosal integrity, leading to
severe injury in the gut [30, 31].
Oxidative stress and its consequent lipid peroxidation
could aggravate free radical chain reactions, disrupt the
integrity of the intestinal mucosal barrier, and activate
inflammatory mediators. It has been shown that colonic CAT
and GSH-Px activity and GSH levels are decreased while lipid
peroxidation (TBARS levels) is increased in experimental
and clinical studies [32, 33].
CAT, GSH-Px, and GSH, as primary defenses, could
reduce the oxidative stress and the activation of inflamma-
tory mediators; R. mangle acting as free radical scavenger
could counteract the function of ROS and directly scavenge
hydroxyl radicals and peroxyl radical species [31]. In our
study, compared with the noncolitic group, the activities of
CAT and GSH-Px with GSH levels in colon tissues dwindled
remarkably in the colitic nontreated group. Therapy with
BuOH fraction or EtOAc fraction for 21 days resulted in
a marked increase in CAT and GSH-Px activities (Table 3)
in colon tissues; however, only BuOH fraction treatment
was capable of reducing TBARS levels (Table 4). In addition,
these treatments resulted in colonic GSH levels (Table 4)
increase. Our results suggested that both BuOH fraction and
EtOAc fraction inhibited oxidative stress induced by TNBS.
The beneficial effects of these treatments are due, partly, to
the antioxidant capacity of the compounds presented in its
composition.
Recently, we published a study on the antioxidant effects
of BuOH fraction in experimental models of gastric ulcer [8];
the study shows that BuOH fraction can protect the gastric
mucosa through the enhancement of antioxidant mediators
and enzymes, such as GSH, GSH-Px, GSH-Rd, SOD as well
as diminishing MPO activity and lipid peroxidation. Thus,
the previous results are in accordance with the present data
regarding the different tissues and pathogenesis between the
respective models.
The expression of COX-2, but not COX-1, is stimulated
after the induction of colitis by TNBS [34], although Hyun









Figure 5: Histological slices of the colon from rats submitted to TNBS-induced colitis assay. HE staining shows comparison of the tissue
architecture between treatments: (a) noncolitic, (b) colitic nontreated, (c) BuOH fraction, and (d) EtOAc fraction.
et al. [35] showed that in PAR2-deficient mice, COX-
1 and COX-2 have their expression augmented after the
induction of colitis by TNBS, and this was associated with
a reduction in inflammation. Thus, during the development
of colitis, both isoforms of COX could together exert an
anti-inflammatory effect. For Reuter et al. [36], COX-1 and
COX-2 have an active role in modulating the inflammatory
process in various experimental models of colitis, since the
administration of selective inhibitors of COX-1 or COX-
2 in models of TNBS and DSS-induced colitis increased
the severity of colitis and harmed the healing process.
In this context, our results (Figure 4) suggest that BuOH
fraction exerts its anti-inflammatory through a similar
mechanism since the expression of both COX-1 and COX-2
was increased in this group, while EtOAc fraction presented
similar levels of expression of these enzymes found in colitic
nontreated group.
Cytokines are essential mediators of the interactions
between activated immune cells and nonimmune cells,
including epithelial and mesenchymal cells. The clinical
efficacy of TNF-α clearly indicates that cytokines are one
of the therapeutic targets of chronic inflammatory disorders
such as IBD [37].
TNF-α is a major mediator of inflammation in the gut.
It is synthesized by several cells including intestinal epithelial
cells but predominantly by cells of the monocytic line and
T lymphocytes. TNF-α induces the expression of various
genes; it has multiple biological effects such as increasing
leukocyte recruitment, modulation of nitric oxide pro-
duction, induction of proinflammatory cytokine secretion,
and the proliferation and differentiation of immune cells
[3].
Our results showed that both treatments BuOH fraction
and EtOAc fraction provided downregulation of TNF-α
levels (Table 5), suggesting that these compounds could
act on the activation of this cytokine. Interestingly BuOH
fraction and EtOAc fraction also decreased the levels of IL-
12 (Table 5), which are linked to the suppression of TNF-
α; this fact may possibly explain this mechanism by which
both treatments ameliorate the inflammation scenario.
Anti-IL-12 or interferon-γ-specific antibodies antagonize
the development of spontaneous IBD in IL-10-deficient
mice, but only neutralization of IL-12 ameliorated the
disease [4]. IL-12 blockade inhibits the generation of
Th1 response and abrogates the production of the down-
stream cytokines (T-cell derived TNF-α, IFN-γ, and IL-12
itself).
Overproduction of IL-12, a macrophage-derived cytok-
ine, shifts the immune response in a Th-1direction; this
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Noncolitic 357.3 ± 20.7∗∗∗ 209.1 ± 24.3∗∗∗ 12.7 ± 1.9∗∗∗ 295.0 ± 37.7∗∗∗
Colitic nontreated 1381.0 ± 227.5 807.3 ± 45.5 28.5 ± 2.4 120.4 ± 4.3
BuOH fraction 0.5 mg/Kg 469.5 ± 21.5∗∗∗ 719.1 ± 17.4 16.72 ± 1.0∗∗∗ 152.5 ± 11.6
EtOAc fraction 1.5 mg/Kg 567.9 ± 21.8∗∗∗ 615.4 ± 54.4∗∗ 19.09 ± 1.7∗∗ 252.1 ± 19.3∗∗
Results are presented as mean ± SEM ANOVA followed by Dunnett’s t-test, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from colitic
nontreated.
response is characterized by increased production of TNF-
α and IL-6 resulting in a self-sustaining cycle of activation
[38]. IL-6 is a pleiotropic cytokine that plays a crucial role
in inflammation, immune regulation, hematopoiesis, and
oncogenesis; there is growing evidence that an IL-6 signaling
pathway plays a crucial part in the uncontrolled intestinal
inflammatory process of IBD [39]. The evaluation of this
proinflammatory cytokine revealed that EtOAc fraction
decreased its level; however, BuOH fraction showed no
effects on its levels.
These proinflammatory cytokines act on local cell
populations to promote intracellular killing (superox-
ides, peroxides), enhance recruitment of other inflamma-
tory cells, enhance secretion of chemoattractant cytokines
(chemokines), and promote local tissue destruction [40].
Mucosal dendritic cells (DCs), in particular, have long been
thought to promote tolerance in the gut. Expanding den-
dritic cells, including those present in the intestinal tissues,
promote the ability to induce oral tolerance. Moreover,
mucosal DCs residing in the lamina propria or Peyer’s
patches of the intestine appear to preferentially produce IL-
10, rather than IL-12 [41].
IL-10 is secreted by a wide variety of cells and has
pleiotropic effects on T cells, B cells, myeloid cells, and other
cell types. IL-10 has suppressive anti-inflammatory activity
on T cells, macrophages, and dendritic cells in humans, as
well as in animal models of inflammatory diseases. Despite
that IL-10 effectively treats colitis in mouse models and
suppresses inflammatory cytokine production in vivo in
intestinal cells from IBD patients [3], in diseases with a
relative or absolute IL-10 deficiency, a persistent immune
activation still exists [42]. Regarding the evaluation of IL-10
(Table 5), the treatments showed different responses again,
while EtOAc fraction increased its level, and BuOH fraction
showed no effect on IL-10 level.
This finding suggests that the main effect of the com-
pounds of EtOAc fraction is likely to act on the activation
of anti-inflammatory IL-10 and on the downregulation of
IL-12, thus resulting in diminished levels of TNF-α and IL-
6. On the other hand, the compounds present in BuOH
fraction possibly exhibited their anti-inflammatory activity
in this model by the regulation of cyclooxygenases as well as
the activity and levels of ROS mediators, especially the lipid
peroxidation (TBARS) and MPO which are also linked to
neutrophil infiltration, thereby promoting healing changes
during the inflammation caused by TNBS.
7. Conclusions
The compounds present in BuOH fraction and EtOAc
fraction are predominantly proanthocyanidins and pro-
cyanidins; these compounds have shown interesting activities
as mentioned previously. In this work, we provided, for
the first time, the evaluation of these compounds from R.
mangle barks on intestinal inflammation as a continuous
study on the benefits of this medicinal plant regarding
the gastrointestinal tract. Here, we showed a promising
evaluation on anti-inflammatory and immune response of
these compounds, and this study must be used for further
studies to help explaining how these compounds lead to these
subtle mechanisms such as activation of IL-10, COX-1, and
other related cells and molecules.
On the structural elucidation of the compounds present
in the bark of R. mangle, further studies must be continued
by our research group, where the extract and active fractions
will be fractionated by classic chromatographic methods for
isolation of substances and identification by spectrometric
methods, in trying to obtain a chemical marker for the
extract.
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